Synonyms: cLLB8 | CNTO 328 | Sylvant®
siltuximab is an approved drug (EMA & FDA (2014))
Compound class:
Antibody
|
Immunopharmacology Comments |
Siltuximab is a drug for an orphan (rare) disease. |
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Multicentric Castleman disease |
OMIM:
148000 Orphanet: ORPHA93686 |
Approved therapeutic for MCD. |